In a patient with a mildly dilated main pulmonary artery (3.3 cm) on CT and a history of prior unprovoked pulmonary embolism, what transthoracic echocardiogram measurements are required to evaluate for pulmonary hypertension, including estimated right‑ventricular systolic pressure via tricuspid regurgitation jet velocity, estimated right‑atrial pressure, pulmonary‑artery systolic pressure, assessment for right‑ventricular pressure overload (septal configuration and motion), right‑ventricular size and function (quantitative measurements), and main pulmonary‑artery diameter?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Comprehensive Transthoracic Echocardiogram Protocol for Pulmonary Hypertension Evaluation

Your repeat transthoracic echocardiogram should include all the following measurements to properly evaluate for pulmonary hypertension in this patient with dilated pulmonary artery and prior PE: tricuspid regurgitation jet velocity (TRV), estimated right atrial pressure via inferior vena cava assessment, right ventricular size and function with quantitative measurements, septal configuration, and pulmonary artery diameter.

Essential Measurements Required

Primary Hemodynamic Assessment

Tricuspid Regurgitation Velocity (TRV):

  • Measure peak TRV using continuous wave Doppler 1, 2
  • This is the most important single measurement for screening pulmonary hypertension 2
  • TRV >2.8 m/s suggests possible PH; TRV 2.9-3.4 m/s indicates intermediate-to-high probability; TRV >3.4 m/s indicates high probability 1, 2, 3, 2
  • If TRV is difficult to measure due to trivial tricuspid regurgitation, consider agitated saline contrast to enhance the Doppler signal 1

Right Atrial Pressure Estimation:

  • Measure inferior vena cava (IVC) diameter at end-expiration 4, 1, 2, 1
  • Assess IVC collapsibility with sniff or quiet inspiration 1, 2, 1
  • IVC <2.1 cm with >50% collapse = estimated RAP 3 mmHg (0-5 mmHg range)
  • IVC >2.1 cm with <50% collapse with sniff or <20% with quiet inspiration = estimated RAP 15 mmHg (10-20 mmHg range)
  • Intermediate scenarios = estimated RAP 8 mmHg (5-10 mmHg range) 1, 2, 1

Pulmonary Artery Systolic Pressure (PASP):

  • Calculate using simplified Bernoulli equation: PASP = 4(TRV)² + estimated RAP 4, 1, 2, 1
  • However, prioritize reporting the TRV value itself rather than the derived PASP, as estimation errors are amplified in derived variables 1, 2

Right Ventricular Assessment for Pressure Overload

RV Size and Geometry:

  • RV/LV basal diameter ratio (abnormal if >1.0) 2, 3, 2
  • RV end-diastolic area 3
  • Interventricular septal configuration and motion 4
    • Look for septal flattening (LV eccentricity index >1.1 in systole and/or diastole) 2, 3, 2
    • D-sign indicates RV pressure overload 4

RV Function - Quantitative Measurements:

  • Tricuspid annular plane systolic excursion (TAPSE) 4
  • RV S' velocity (tissue Doppler at tricuspid annulus) 4
  • RV fractional area change 4
  • RV free wall strain using 2D speckle tracking (strongly predicts outcomes if available) 4
  • RV index of myocardial performance 4

Additional Echocardiographic Signs of Pulmonary Hypertension

Pulmonary Artery Assessment:

  • Main pulmonary artery diameter (abnormal if >25 mm) 2, 3, 2
  • RV outflow tract acceleration time (<105 msec suggests PH) 2, 3, 2
  • Look for mid-systolic notching in RV outflow tract Doppler profile 4, 2, 3, 2, 4
  • Early diastolic pulmonary regurgitation velocity (>2.2 m/s suggests PH) 2, 3, 2

Right Atrial Size:

  • RA area at end-systole (abnormal if >18 cm²) 2, 3, 2

Other Important Findings:

  • Presence and severity of tricuspid regurgitation 4
  • Pericardial effusion (moderate or large effusion predicts worse outcomes) 4

Probability Assessment Framework

The echo should assign a probability of PH based on the combination of findings 1, 2, 3, 2:

High Probability PH:

  • TRV 2.9-3.4 m/s PLUS at least 2 categories of additional PH signs (ventricular, PA, or IVC/RA findings)
  • OR TRV >3.4 m/s (regardless of other findings)

Intermediate Probability PH:

  • TRV ≤2.8 m/s PLUS presence of additional PH signs from at least 2 categories
  • OR TRV 2.9-3.4 m/s without additional PH signs

Low Probability PH:

  • TRV ≤2.8 m/s without additional PH signs

Critical Context for This Patient

Given this patient's history of prior unprovoked PE and dilated main PA (3.3 cm), you need to distinguish between:

  1. Chronic thromboembolic pulmonary hypertension (CTEPH) - a treatable cause requiring referral to expert centers 5, 6
  2. Residual PA dilation without significant PH
  3. Other causes of precapillary PH

Key distinguishing features to assess:

  • In chronic PH (including CTEPH), expect RV hypertrophy (RV free wall thickness >5 mm), RA enlargement greater than LA size, and higher TR velocities (typically >3.4 m/s) 7
  • Severely dilated and remodeled RV with notching of RV outflow tract suggests precapillary etiology 4
  • Assess for left heart disease (LV hypertrophy, systolic/diastolic dysfunction, valvular disease, increased LA volume) which would suggest postcapillary PH 4

Important Caveats

  • Echocardiography alone cannot definitively diagnose PH - right heart catheterization remains the gold standard 1, 2, 1
  • TRV measurement can be inaccurate in individual patients; severe TR may significantly underestimate pressures 1
  • Absence of measurable TR jet does not exclude PH 8
  • If intermediate or high probability PH is found, the patient requires right heart catheterization before initiating PH-specific therapy 1, 2, 3, 2
  • Given the prior unprovoked PE, ventilation/perfusion scan should also be performed to screen for CTEPH (sensitivity >90%, specificity >94%) 9

Follow standardized echocardiographic guidelines for measurement techniques to minimize variability 4.

References

Guideline

acr appropriateness criteria® suspected pulmonary hypertension: 2022 update.

Journal of the American College of Radiology, 2022

Research

Chronic thromboembolic pulmonary disease.

The European respiratory journal, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.